ArticleInternal medicine journal2026
Application value of the impulse oscillometry system in the airway evaluation of patients with chronic obstructive pulmonary disease in different age groups.
Article in Internal medicine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe impulse oscillometry system (IOS) uses a tidal-breathing method requiring considerably less patient cooperation than conventional spirometry, thereby more accurately reflecting normal respiratory physiology.
aimTo investigate the application value of the IOS in evaluating the airways of patients with chronic obstructive pulmonary disease (COPD) across different age groups in China.
methodsThis retrospective cohort study enrolled 115 COPD patients and 103 healthy volunteers, categorised into young/middle-aged (≤60 years) and elderly (>60 years) groups. Participants underwent IOS and conventional pulmonary function tests. Logistic regression and receiver operating characteristic (ROC) curves were used to evaluate the sensitivity, specificity and optimal cut-off values of key IOS parameters - including resonance frequency (Fres), low-frequency reactance area (AX) and resistance percentage (R5-R20%R5) - to distinguish COPD patients within each age stratum.
resultsFor young and middle-aged patients, the area under the curve (AUC) of AX was 0.838 (95% confidence interval (CI): 0.756-0.921, P < 0.001); a cut-off value of 1.36 kPa/L yielded 83.7% sensitivity and 75.0% specificity. For elderly patients, the AUC of R5-R20%R5 was 0.849 (95% CI: 0.775-0.924, P < 0.001); a cut-off value of 48.68% achieved 76.4% sensitivity and 97.9% specificity. Additionally, the AUC of Fres in the elderly was 0.734 (95% CI: 0.646-0.823, P < 0.001; cut-off: 22.75 Hz; sensitivity: 56.9%; specificity: 87.2%).
conclusionChanges in AX are sensitive indicators for early COPD screening in young and middle-aged individuals. Furthermore, R5-R20%R5 and Fres serve as highly specific and reliable diagnostic parameters for elderly patients, particularly those unable to cooperate with conventional spirometry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.